From: Is crystalloid cardioplegia a strong predictor of intra-operative hemodilution?
Variable | Crystalloid cardioplegia [no = 50] | Blood cardioplegia [no = 50] | p value |
---|---|---|---|
Age* | 61 ± 12 | 63 ± 9 | 0.651 |
Male | 37 | 39 | 0.466 |
Smoking | 34 | 29 | 0.012 |
COPD | 12 | 14 | 0.834 |
Hypertension | 25 | 21 | 0.543 |
Congestive heart failure (no) | 2 | 3 | 0.335 |
Peripheral vascular disease | 11 | 9 | 0.746 |
Cerebral vascular disease | 6 | 7 | 1.00 |
Average body surface area (BSA m2) | 1.91 ± 0.5 | 1.89 ± 2.2 | 0.855 |
Body mass index (kg/m2)* | 33.4 ± 4.2 | 29.3 ± 6.8 | 0.455 |
Ejection fraction (%)* | 45.6 ± 7.8 | 50.1 ± 3.6 | 0.023 |
Preoperative IABP | 2 | - | 0.242 |
Number of diseased vessels* (range 1–4) | 2.1 ± 0.4 | 1.9 ± 0.6 | 0.744 |
LMCA disease (>50%) | 5 | 3 | 0.721 |
Previous MI | 31 | 37 | 0.462 |
Previous PTCA or stent | 8 | 11 | 0.631 |
Preoperative hematocrit value (%) | 38.5 ± 3.7 | 40.4 ± 5.6 | 0.563 |
Preoperative hemoglobine value (gr/dL) | 13.3 ± 2.3 | 13.9 ± 2.9 | 0.646 |